Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | microtubule-associated protein tau | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma japonicum | ko:K04380 microtubule-associated protein tau, putative | Get druggable targets OG5_133504 | All targets in OG5_133504 |
Schistosoma mansoni | microtubule-associated protein tau | Get druggable targets OG5_133504 | All targets in OG5_133504 |
Echinococcus granulosus | microtubule associated protein 2 | Get druggable targets OG5_133504 | All targets in OG5_133504 |
Echinococcus multilocularis | microtubule associated protein 2 | Get druggable targets OG5_133504 | All targets in OG5_133504 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | transitional endoplasmic reticulum atpase | 0.118 | 1 | 1 |
Entamoeba histolytica | cdc48-like protein, putative | 0.1119 | 0.9457 | 1 |
Entamoeba histolytica | transitional endoplasmic reticulum ATPase, putative | 0.1119 | 0.9457 | 1 |
Trichomonas vaginalis | spermatogenesis associated factor, putative | 0.118 | 1 | 1 |
Echinococcus multilocularis | transitional endoplasmic reticulum atpase | 0.0488 | 0.3817 | 0.3817 |
Trypanosoma cruzi | katanin, putative | 0.0061 | 0.0000041468 | 0.0000043848 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0833 | 0.6903 | 0.6903 |
Trypanosoma brucei | Valosin-containing protein | 0.1119 | 0.9457 | 1 |
Plasmodium vivax | cell division cycle protein 48 homologue, putative | 0.1119 | 0.9457 | 1 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0833 | 0.6903 | 0.6903 |
Loa Loa (eye worm) | fidgetin protein | 0.0061 | 0.0000041468 | 0.0000073523 |
Mycobacterium ulcerans | ATPase | 0.0706 | 0.5767 | 0.5 |
Plasmodium falciparum | cell division cycle protein 48 homologue, putative | 0.1119 | 0.9457 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0692 | 0.564 | 1 |
Schistosoma mansoni | cell division control protein 48 aaa family protein | 0.118 | 1 | 1 |
Loa Loa (eye worm) | ATPase | 0.0061 | 0.0000041468 | 0.0000073523 |
Trypanosoma cruzi | katanin, putative | 0.0061 | 0.0000041468 | 0.0000043848 |
Loa Loa (eye worm) | vesicle-fusing ATPase | 0.0692 | 0.564 | 1 |
Toxoplasma gondii | cell division protein CDC48AP | 0.0706 | 0.5767 | 0.5767 |
Schistosoma mansoni | cell division control protein 48 aaa family protein | 0.0488 | 0.3817 | 0.3817 |
Trypanosoma cruzi | metalloprotease, putative | 0.0061 | 0.0000041468 | 0.0000043848 |
Trypanosoma cruzi | katanin, putative | 0.0061 | 0.0000041468 | 0.0000043848 |
Trypanosoma cruzi | katanin-like protein, putative | 0.0061 | 0.0000041468 | 0.0000043848 |
Onchocerca volvulus | Transitional endoplasmic reticulum ATPase homolog | 0.118 | 1 | 0.5 |
Trypanosoma cruzi | vesicular transport protein (CDC48 homologue), putative | 0.0061 | 0.0000041468 | 0.0000043848 |
Brugia malayi | vesicle-fusing ATPase | 0.0692 | 0.564 | 1 |
Trichomonas vaginalis | proteasome-activating nucleotidase, putative | 0.0279 | 0.195 | 0.195 |
Toxoplasma gondii | cell division protein CDC48CY | 0.118 | 1 | 1 |
Brugia malayi | ATPase, AAA family protein | 0.0061 | 0.0000041468 | 0.0000073523 |
Trichomonas vaginalis | 26S protease regulatory subunit S10b, putative | 0.0279 | 0.195 | 0.195 |
Trypanosoma cruzi | katanin, putative | 0.0061 | 0.0000041468 | 0.0000043848 |
Giardia lamblia | AAA family ATPase | 0.0706 | 0.5767 | 1 |
Mycobacterium tuberculosis | Putative conserved ATPase | 0.0706 | 0.5767 | 0.5 |
Trypanosoma cruzi | Valosin-containing protein, putative | 0.1119 | 0.9457 | 1 |
Loa Loa (eye worm) | VCP protein | 0.0488 | 0.3817 | 0.6768 |
Brugia malayi | vps4b-prov protein | 0.0061 | 0.0000041468 | 0.0000073523 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0833 | 0.6903 | 0.6903 |
Brugia malayi | transitional endoplasmic reticulum ATPase TER94, putative | 0.0488 | 0.3817 | 0.6768 |
Brugia malayi | valosin containing protein | 0.0692 | 0.564 | 1 |
Schistosoma mansoni | cell division control protein 48 aaa family protein | 0.1119 | 0.9457 | 0.9457 |
Trypanosoma cruzi | vacuolar transport protein 4A, putative | 0.0061 | 0.0000041468 | 0.0000043848 |
Toxoplasma gondii | transitional endoplasmic reticulum ATPase, putative | 0.0706 | 0.5767 | 0.5767 |
Trypanosoma cruzi | vacuolar protein sorting-associated protein 4, putative | 0.0061 | 0.0000041468 | 0.0000043848 |
Leishmania major | Transitional endoplasmic reticulum ATPase, putative,valosin-containing protein homolog | 0.1119 | 0.9457 | 1 |
Trypanosoma cruzi | katanin, putative | 0.0061 | 0.0000041468 | 0.0000043848 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 15.8489 um | PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.